Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > I think pakerfan needs more shares

<< Previous

Bullboard Posts

Next >>

Comment by Packerfan666on May 05, 2020 1:15pm

92 Views

Post# 30988567

RE:I think pakerfan needs more shares

Chief Bronco is truly a Moron. I have never told anyone to sell or tried to create fear. I have stated facts . 90% good the first couple years . Then 10% concerns and people like him can't handle it. But I was right about everything. But of course he won't comment on that. He just keeps lumping me in with someone who changes profiles everyday. Pure stupidity this guy is

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth